SCYNEXIS, Inc.
SCYXSCYNEXIS, Inc.
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.90
+0.01(1.3%)
52W $0.58 – $1.18
Quick:
8-K
Mar 31, 2026 (6 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 31, 2026 (6 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 31, 2026 (6 days ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 4, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Jan 8, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 12, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 5, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 15, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Oct 7, 2025 (6 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Aug 13, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Jul 1, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 26, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 15, 2025 (10 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
10-K
Mar 12, 2025 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 14, 2025 (1 years ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Jan 8, 2025 (1 years ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SC 13G/A
Nov 14, 2024 (1 years ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active